Rapiscan Laboratories, Inc., a leading name in the security and inspection industry, is headquartered in the United States. Founded in 1993, the company has established itself as a pioneer in developing advanced screening technologies for various sectors, including aviation, border security, and critical infrastructure. Rapiscan is renowned for its innovative products, such as high-energy X-ray systems and advanced threat detection solutions, which are designed to enhance safety and efficiency in security operations. With a strong market presence and a commitment to excellence, Rapiscan has achieved significant milestones, including numerous industry awards and certifications that underscore its reputation for reliability and performance. As a trusted partner for governments and businesses worldwide, Rapiscan Laboratories continues to lead the way in providing cutting-edge security solutions that meet the evolving challenges of a dynamic global landscape.
How does Rapiscan Laboratories, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Rapiscan Laboratories, Inc.'s score of 35 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Rapiscan Laboratories, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of OSI Systems, Inc., which may influence its climate commitments and emissions reporting. As of now, there are no documented reduction targets or climate pledges from Rapiscan Laboratories, Inc. However, emissions data and performance metrics may be inherited from its parent company, OSI Systems, Inc. This relationship suggests that any climate initiatives or targets may be aligned with those of OSI Systems, although specific details are not provided. In the absence of direct emissions data or reduction commitments, it is essential to monitor future disclosures from Rapiscan Laboratories, Inc. and its parent company to understand their overall impact on carbon emissions and climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2024 | |
|---|---|---|
| Scope 1 | 10,060,000 | 0,000,000 |
| Scope 2 | 17,856,000 | 00,000,000 |
| Scope 3 | 2,700,000 | 0,000,000 |
Rapiscan Laboratories, Inc.'s Scope 3 emissions, which increased by 78% last year and increased by approximately 78% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 19% of total emissions under the GHG Protocol, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Rapiscan Laboratories, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.